| Literature DB >> 29709709 |
Daniel H Lopez1, Joan Bestard-Escalas2, Jone Garate3, Albert Maimó-Barceló4, Roberto Fernández5, Rebeca Reigada6, Sam Khorrami7, Daniel Ginard8, Toshiro Okazaki9, José A Fernández10, Gwendolyn Barceló-Coblijn11.
Abstract
Human colon lipid analysis by imaging mass spectrometry (IMS) demonstrates that the lipid fingerprint is highly sensitive to a cell's pathophysiological state. Along the colon crypt axis, and concomitant to the differentiation process, certain lipid species tightly linked to signaling (phosphatidylinositols and arachidonic acid (AA)-containing diacylglycerophospholipids), change following a rather simple mathematical expression. We extend here our observations to ethanolamine plasmalogens (PlsEtn), a unique type of glycerophospholipid presenting a vinyl ether linkage at sn-1 position. PlsEtn distribution was studied in healthy, adenomatous, and carcinomatous colon mucosa sections by IMS. In epithelium, 75% of PlsEtn changed in a highly regular manner along the crypt axis, in clear contrast with diacyl species (67% of which remained constant). Consistently, AA-containing PlsEtn species were more abundant at the base, where stem cells reside, and decreased while ascending the crypt. In turn, mono-/diunsaturated species experienced the opposite change. These gradients were accompanied by a gradual expression of ether lipid synthesis enzymes. In lamina propria, 90% of stromal PlsEtn remained unchanged despite the high content of AA and the gradient in AA-containing diacylglycerophospholipids. Finally, both lipid and protein gradients were severely affected in polyps and carcinoma. These results link PlsEtn species regulation to cell differentiation for the first time and confirm that diacyl and ether species are differently regulated. Furthermore, they reaffirm the observations on cell lipid fingerprint image sensitivity to predict cell pathophysiological status, reinforcing the translational impact both lipidome and IMS might have in clinical research.Entities:
Keywords: Colonocyte differentiation; Colorectal cancer; Ethanolamine ether lipids; Imaging mass spectrometry; Lipidomics; MALDI-imaging; Plasmalogens
Mesh:
Substances:
Year: 2018 PMID: 29709709 DOI: 10.1016/j.bbalip.2018.04.017
Source DB: PubMed Journal: Biochim Biophys Acta Mol Cell Biol Lipids ISSN: 1388-1981 Impact factor: 4.698